A case report of ventricular fibrillation following Shockwave intravascular lithotripsy during percutaneous coronar… pubmed.ncbi.nlm.nih.gov/38654211/
First time I saw this

Excellent thread with possible causes for reversal in Heart Failure mortality rates Mamas A. Mamas James Januzzi Jr MD Dorian L. Beasley MD, FACC
👇🏽

ℙ𝕒𝕣𝕒𝕝𝕝𝕖𝕝 𝕎𝕚𝕣𝕖𝕤 𝕒𝕟𝕕 𝕄𝕚𝕟𝕚𝕞𝕒𝕝𝕚𝕤𝕥 ℂ𝕋𝕆?

RCA #CTO 1/ 🧵

Nightmare in the cath lab 😱

The balloon gets stuck after post-dilation. It gets worse the shaft breaks when you try to pull the system out - you can't retrieve it, you can't snare it.

😨What would you do?

jeroen sonck jcspratt PCRonline 🫀

DK Crush step by step. Ideal case for #ACCFIT . Stable 50sM w “nml perfusion” but global ischemia EKG pattern. Tom Wilson Umair Khalid Mamas A. Mamas Adil S Wani Aditya Bharadwaj Antonious Attallah, MD, FACC, FSCAI Allison Dupont, MD Nyal Borges Christian McNeely Dr Shariq Shamim jedicath աǟզǟʀ.ǟɦʍɛɖ Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI Jimmy Kerrigan

I am today old when I discovered AI. Although it still can't get what an catheterization image intensifier is.

From the internet / smart device age humans will enter the AI age.

#CTO #epicardial #PTCA 53yo male patient with CTO Cx-OM and 2 failed attempts (dissection, hematoma). Ipsilateral retrograde tracking from Diag to OM with Suoh 0.3. then Gaia3rd supported with CorsairPro tracking from antegrade toward retrograde marker wire.

Preventive stents for 'vulnerable' plaque made a big splash at the #ACC2024

The PREVENT trial is an interesting and bold study. But. But. It's just a beginning.

My thoughts are up on theheartorg | Medscape

medscape.com/viewarticle/pr…

My TCTMD video around the The PREVENT Trial with Ziad Ali and J Dawn Abbott
➡️tctmd.com/videos/beyond-…

➡️Could we not achieve similar results with PCSK9i?
➡️ Should be treat vulnerable plaques with PCI now based on this trial?

#EidMubarak everyone..mark your calendars for the next

ᵒᴼᵒ▫ₒₒ▫ᵒᴼᵒ▫ₒₒ▫ᵒᴼᵒ ▫ᵒᴼᵒ ᵒ
🆃🅲🆃 🅼🅸🅳🅳🅻🅴 🅴🅰🆂🆃 ᵒᴼᵒ▫ₒₒ▫ᵒᴼᵒ▫ₒₒ▫ᵒᴼᵒ ▫ᵒᴼᵒ ᵒ

This is not your conventional meeting…②⓪②⑤

Regional Course Directors: Khaled AlShaibi Dr.Khalid Al Faraidyالدكتور خالد الفرائضي

#CTOLIVEAID2024 : Are you ready to unlock the secrets of #InterventionalCardiology ?

Join us for an enlightening slot showcasing live cases by:
Maksymilian Opolski from the Institute of Cardiology
Pierfrancesco Agostoni from Ziekenhuis Netwerk Antwerpen

Boston Scientific, Gregor Leibundgut, Ilya Litovchik

58 yr old male, secundum ASD 34 mm adv surgery previously, lost to follow up and presented with HF after onset of AF. ASD shunting left to right shunt, Severe TR, MR as shown in A4C. Cath showed LVEDP18, QP/QS 2.2:1, RVSP 62. LAD total occlusion, OM&RCA tight lesions. Your advise

Astonishing results from the DanGer Shock Trial presented at #ACC24 and out in NEJM today.

In patients with ST-elevation MI with cardiogenic shock, Impella reduced all-cause mortality (45.8% Impella vs. 58.5% control) at 180 days.

Some thoughts on this ground breaking trial:

This matters!!!! Joe Biden CMSGov U.S. FDA Dr. Robert M. Califf
Physicians are exhausted!!

1/
DanGer Shock Trial

“Impella might finally get to brag about a positive trial”!

nejm.org/doi/full/10.10…

📢💡 #Cardiac #CTA is increasingly utilized to assess pts' coronary anatomy. For many pts, it offers a noninvasive way to evaluate the need for heart catheterization & can enhance ICs info in the cath lab.

➡️doi.org/10.1016/j.jsca…

#JSCAI #Cardiac CTA Special Issue📚